Skip to main content

Featured

Fed Poised for Rate Cut, Signals Limited Easing Ahead

                                                          US Federal Reserve Chair Jerome Powell The Federal Reserve is widely expected to cut interest rates at its upcoming meeting, marking a shift in monetary policy aimed at supporting economic growth amid cooling inflation and slowing demand. While markets have anticipated a series of reductions, policymakers appear cautious, with signals suggesting only one additional cut may be on the horizon for next year. This measured approach reflects the Fed’s balancing act: easing financial conditions to sustain momentum while avoiding overstimulation that could reignite price pressures. Investors are closely watching the central bank’s language for clues on the trajectory of borrowing costs, as households and businesses continue to navigate a delicate economic environment....
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment